Sponsor study identifier
Secondary identifiers
observational
10
1 country
1
Study Start
January 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
September 2005
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Severe acute respiratory syndrome (SARS) is a new emerging infectious disease. Its pathogen is a newly discovered coronavirus (SARS-CoV). The clinical course can be classified to 3 stages: viral replication phase, hyperimmune reactive phase, and pulmonary destruction phase. Human monocyte plays a critical role in the initiation of immune response in defending the intracellular pathogens (eg viruses). Monocytes can engulf viruses and present the viral antigens in the major histocompatibility (MHC) molecule to the cell surface to initiate T lymphocyte response. Monocytes also secrete various cytokines to modulate immune response. SARS-CoV is a mutant of animal virus to cause human disease and is able to cause unusual severe respiratory illness. It is suggested the unusual severe disease is due to the intense immune reaction. The investigators will harvest human monocytes from healthy adult and children blood donors. Monocytes would be cultured and infected by SARS-CoV. The change of viral load is monitored after infection. Cytokines secreted by monocytes after infection are also measured. The difference of monocyte cytokine secretion is compared between adults and children. The study is to verify the SARS-CoV infectivity of human monocytes and prove the unusual severity caused by SARS-CoV is related to viral-induced dysregulation of cytokine responses. The results may also clarify why adults tend to have a more severe illness compared with children.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2005
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2005
Date type not reportedThis date has not been verified as actual or estimated.
September 2005
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
September 12, 2005
Actual (reported)September 15, 2005
Actual (reported)Contact the study team to confirm eligibility.
National Taiwan University Hospital
Taipei, 100, Taiwan
Luan-Yin Chang, MD, PhD
Department of pediatrics, National Taiwan University Hospital
First Submitted
September 12, 2005
First Posted
September 15, 2005
Study Start
January 2005
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
September 2005
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Glucose Monitor Accuracy Investigation (Ⅰ)
Last Updated
December 3, 2007
Record last verified: 2005-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: